The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets
Open accessAbstract
Chronic kidney disease (CKD) is a major public health issue. At the histological level, renal fibrosis is the final common pathway of progressive kidney disease irrespective of the initial injury. Considerable evidence now indicates that renal inflammation plays a central role in the initiation and progression of CKD. Some of the inflammatory signaling molecules involved in CKD include: monocyte chemoattractant protein‐1 (MCP‐1), bradykinin B1 receptor (B1R), nuclear factor &kgr;B (NF‐&kgr;B), tumor necrosis factor‐&agr; (TNF&agr;), transforming growth factor &bgr; (TGF‐&bgr;), and platelet‐derived growth factor (PDGF). Multiple antifibrotic factors, such as interleukin‐10 (IL‐10), interferon‐&ggr; (IFN‐&ggr;), bone morphogenetic protein‐7 (BMP‐7), hepatocyte growth factor (HGF) are also downregulated in CKD. Therefore, restoration of the proper balance between pro‐ and antifibrotic signaling pathways could serve as a guiding principle for the design of new antifibrotic strategies that simultaneously target many pathways. The purpose of this review is to summarize the existing body of knowledge regarding activation of cytokine pathways and infiltration of inflammatory cells as a starting point for developing novel antifibrotic therapies to prevent progression of CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Ai, J., Nie, J., He, J., Guo, Q., Li, M., Lei, Y., Liu, Y., Zhou, Z., Zhu, F., Liang, M., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014040363 · Cited by 78
RetractedElseweidy, M. M., Askar, M. E., El-Swefy, S. E., & Shawky, M. (2017) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-017-2631-0 · Cited by 24
RetractedRegulation of the Voltage Gated K+ Channel Kv1.3 by Recombinant Human Klotho Protein
Almilaji, A., Honisch, S., Liu, G., Elvira, B., Ajay, S. S., Hosseinzadeh, Z., Ahmed, M., Munoz, C., Sopjani, M., & Lang, F. (2014) · Kidney and Blood Pressure Research · doi:10.1159/000368472 · Cited by 5,592
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Chronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
TGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528
Non-Transgenic Mouse Models of Kidney Disease
Rabe, M., & Schaefer, F. (2016) · Nephron · doi:10.1159/000445171 · Cited by 1,922
Cellular and molecular mechanisms of renal fibrosis
Liu, Y. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.149 · Cited by 1,446
Zeisberg, M., Hanai, J.-I., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., & Kalluri, R. (2003) · Nature Medicine · doi:10.1038/nm888 · Cited by 1,346
Renal fibrosis: New insights into the pathogenesis and therapeutics
Liu, Y. (2006) · Kidney International · doi:10.1038/sj.ki.5000054 · Cited by 1,089
Gao, X., Wu, G., Gu, X., Fu, L., & Mei, C. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000355743 · Cited by 1,035
Ligand-Induced, Receptor-Mediated Dimerization and Activation of EGF Receptor
Schlessinger, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00966-2 · Cited by 993
Trends in Chronic Kidney Disease in China
Zhang, L., Long, J., Jiang, W., Shi, Y., He, X., Zhou, Z., Li, Y., Yeung, R. O., Wang, J., Matsushita, K., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1602469 · Cited by 765
The immune system and kidney disease: basic concepts and clinical implications
Kurts, C., Panzer, U., Anders, H.-J., & Rees, A. J. (2013) · Nature Reviews Immunology · doi:10.1038/nri3523 · Cited by 696
de Zeeuw, D., Agarwal, R., Amdahl, M., Audhya, P., Coyne, D., Garimella, T., Parving, H.-H., Pritchett, Y., Remuzzi, G., Ritz, E., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61032-x · Cited by 695
ErbB Receptors: Directing Key Signaling Networks Throughout Life
Holbro, T., & Hynes, N. E. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121440 · Cited by 640
Cellular and molecular mechanisms in kidney fibrosis
Duffield, J. S. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72267 · Cited by 629
Trends in Prevalence of Chronic Kidney Disease in the United States
Murphy, D., McCulloch, C. E., Lin, F., Banerjee, T., Bragg-Gresham, J. L., Eberhardt, M. S., Morgenstern, H., Pavkov, M. E., Saran, R., Powe, N. R., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0273 · Cited by 616
Doi, S., Zou, Y., Togao, O., Pastor, J. V., John, G. B., Wang, L., Shiizaki, K., Gotschall, R., Schiavi, S., Yorioka, N., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.174037 · Cited by 532
YAP/TAZ Are Mechanoregulators of TGF-β-Smad Signaling and Renal Fibrogenesis
Szeto, S. G., Narimatsu, M., Lu, M., He, X., Sidiqi, A. M., Tolosa, M. F., Chan, L., De Freitas, K., Bialik, J. F., Majumder, S., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050499 · Cited by 462
AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function
Dugan, L. L., You, Y.-H., Ali, S. S., Diamond-Stanic, M., Miyamoto, S., DeCleves, A.-E., Andreyev, A., Quach, T., Ly, S., Shekhtman, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66218 · Cited by 456
Shedding light on ADAM metalloproteinases
Huovila, A.-P. J., Turner, A. J., Pelto-Huikko, M., Kärkkäinen, I., & Ortiz, R. M. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.05.006 · Cited by 453
Interactions of Transforming Growth Factor-β and Angiotensin II in Renal Fibrosis
Border, W. A., & Noble, N. A. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.181 · Cited by 447
MicroRNAs in kidney physiology and disease
Trionfini, P., Benigni, A., & Remuzzi, G. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.202 · Cited by 353
Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach
Lautrette, A., Li, S., Alili, R., Sunnarborg, S. W., Burtin, M., Lee, D. C., Friedlander, G., & Terzi, F. (2005) · Nature Medicine · doi:10.1038/nm1275 · Cited by 343
Blockade of CCR2 Ameliorates Progressive Fibrosis in Kidney
Kitagawa, K., Wada, T., Furuichi, K., Hashimoto, H., Ishiwata, Y., Asano, M., Takeya, M., Kuziel, W. A., Matsushima, K., Mukaida, N., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63292-0 · Cited by 330
Pirfenidone for Diabetic Nephropathy
Sharma, K., Ix, J. H., Mathew, A. V., Cho, M., Pflueger, A., Dunn, S. R., Francos, B., Sharma, S., Falkner, B., McGowan, T. A., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010101049 · Cited by 319
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Zhang, Z., Sun, L., Wang, Y., Ning, G., Minto, A. W., Kong, J., Quigg, R. J., & Li, Y. C. (2008) · Kidney International · doi:10.1038/sj.ki.5002572 · Cited by 305
Self-citationde Zeeuw, D., Bekker, P., Henkel, E., Hasslacher, C., Gouni-Berthold, I., Mehling, H., Potarca, A., Tesar, V., Heerspink, H. J. L., & Schall, T. J. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00261-2 · Cited by 273
Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action
Liu, Y. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00451.2003 · Cited by 265
Blockade of Wnt/β-Catenin Signaling by Paricalcitol Ameliorates Proteinuria and Kidney Injury
He, W., Kang, Y. S., Dai, C., & Liu, Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121236 · Cited by 259
AMPK Mediates the Initiation of Kidney Disease Induced by a High-Fat Diet
Declèves, A.-E., Mathew, A. V., Cunard, R., & Sharma, K. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011010026 · Cited by 251
Chow, F. Y., Nikolic-Paterson, D. J., Ma, F. Y., Ozols, E., Rollins, B. J., & Tesch, G. H. (2007) · Diabetologia · doi:10.1007/s00125-006-0497-8 · Cited by 250
Klotho and Chronic Kidney Disease
Hu, M. C., Kuro-o, M., & Moe, O. W. (2013) · Contributions to Nephrology · doi:10.1159/000346778 · Cited by 224
Pirfenidone Slows Renal Function Decline in Patients with Focal Segmental Glomerulosclerosis
Cho, M. E., Smith, D. C., Branton, M. H., Penzak, S. R., & Kopp, J. B. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01050207 · Cited by 222
A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation
Anders, H.-J., Vielhauer, V., Frink, M., Linde, Y., Cohen, C. D., Blattner, S. M., Kretzler, M., Strutz, F., Mack, M., Gröne, H.-J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14040 · Cited by 207
Soetikno, V., Sari, F. R., Lakshmanan, A. P., Arumugam, S., Harima, M., Suzuki, K., Kawachi, H., & Watanabe, K. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200540 · Cited by 197
Potential approaches to reverse or repair renal fibrosis
Tampe, D., & Zeisberg, M. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.14 · Cited by 195
Yang, J., Dai, C., & Liu, Y. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2003090795 · Cited by 186
A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation
Anders, H.-J., Vielhauer, V., Frink, M., Linde, Y., Cohen, C. D., Blattner, S. M., Kretzler, M., Strutz, F., Mack, M., Gröne, H.-J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214040 · Cited by 183
Therapeutic targets for treating fibrotic kidney diseases
Lee, S.-Y., Kim, S. I., & Choi, M. E. (2015) · Translational Research · doi:10.1016/j.trsl.2014.07.010 · Cited by 176
Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease
Kok, H. M., Falke, L. L., Goldschmeding, R., & Nguyen, T. Q. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.184 · Cited by 171
Genetic or Pharmacologic Blockade of EGFR Inhibits Renal Fibrosis
Liu, N., Guo, J.-K., Pang, M., Tolbert, E., Ponnusamy, M., Gong, R., Bayliss, G., Dworkin, L. D., Yan, H., & Zhuang, S. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011050493 · Cited by 170
Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy
Kanamori, H., Matsubara, T., Mima, A., Sumi, E., Nagai, K., Takahashi, T., Abe, H., Iehara, N., Fukatsu, A., Okamoto, H., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.148 · Cited by 166
Novel targets of antifibrotic and anti-inflammatory treatment in CKD
Declèves, A., & Sharma, K. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.31 · Cited by 165
Celastrol, an NF-κB Inhibitor, Improves Insulin Resistance and Attenuates Renal Injury in db/db Mice
Kim, J. E., Lee, M., Nam, D. H., Song, H. K., Kang, Y. S., Lee, J. E., Kim, H. W., Joo, J., Hyun, Y. Y., Han, S. Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062068 · Cited by 163
IL-33 Exacerbates Acute Kidney Injury
Akcay, A., Nguyen, Q., He, Z., Turkmen, K., Won Lee, D., Hernando, A. A., Altmann, C., Toker, A., Pacic, A., Ljubanovic, D. G., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010091011 · Cited by 163
Vielhauer, V., Berning, E., Eis, V., Kretzler, M., Segerer, S., Strutz, F., Horuk, R., Gröne, H.-J., Schlöndorff, D., & Anders, H.-J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.66038.x · Cited by 161
IL-10 Suppresses Chemokines, Inflammation, and Fibrosis in a Model of Chronic Renal Disease
Mu, W., Ouyang, X., Agarwal, A., Zhang, L., Long, D. A., Cruz, P. E., Roncal, C. A., Glushakova, O. Y., Chiodo, V. A., Atkinson, M. A., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005030297 · Cited by 154
Role and New Insights of Pirfenidone in Fibrotic Diseases
la Mora, D. A. L.-D., Sánchez-Roque, C., Montoya‐Buelna, M., Sánchez‐Enríquez, S., Lucano‐Landeros, S., Macías‐Barragán, J., & Armendáriz‐Borunda, J. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.11579 · Cited by 150
Curcumin blocks multiple sites of the TGF-β signaling cascade in renal cells
Gaedeke, J., Noble, N. A., & Border, W. A. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00713.x · Cited by 149
Wang, S., LaPage, J. A., & Hirschberg, R. R. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00928.x · Cited by 145
Zhao, Z., Burkly, L. C., Campbell, S., Schwartz, N., Molano, A., Choudhury, A., Eisenberg, R. A., Michaelson, J. S., & Putterman, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7949 · Cited by 142
A nonclassical vitamin D receptor pathway suppresses renal fibrosis
Ito, I., Waku, T., Aoki, M., Abe, R., Nagai, Y., Watanabe, T., Nakajima, Y., Ohkido, I., Yokoyama, K., Miyachi, H., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67804 · Cited by 139
Chronic inhibition of nuclear factor-κB attenuates renal injury in the 5/6 renal ablation model
Fujihara, C. K., Antunes, G. R., Mattar, A. L., Malheiros, D. M. A. C., Vieira, J. M., & Zatz, R. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00184.2006 · Cited by 138
Chen, J., Chen, J., & Harris, R. C. (2012) · Kidney International · doi:10.1038/ki.2012.43 · Cited by 135
Mishra, R., Cool, B. L., Laderoute, K. R., Foretz, M., Viollet, B., & Simonson, M. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800902200 · Cited by 135
Sustained Activation of EGFR Triggers Renal Fibrogenesis after Acute Kidney Injury
Tang, J., Liu, N., Tolbert, E. M., Ponnusamy, M., Ma, L., Gong, R., Bayliss, G. P., Yan, H., & Zhuang, S. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.04.005 · Cited by 131
CTGF Inhibits BMP-7 Signaling in Diabetic Nephropathy
Nguyen, T. Q., Roestenberg, P., van Nieuwenhoven, F. A., Bovenschen, N., Li, Z., Xu, L., Oliver, N., Aten, J., Joles, J. A., Vial, C., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007111261 · Cited by 128
Zhu, F., Shin, O. L.-S. C. L., Pei, G., Hu, Z., Yang, J., Zhu, H. J., Wang, M., Mou, J., Sun, J. L., Wang, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19979 · Cited by 119
Self-citationPirfenidone: an anti-fibrotic therapy for progressive kidney disease
Cho, M. E., & Kopp, J. B. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903501539 · Cited by 118
Role of TWEAK in lupus nephritis: A bench-to-bedside review
Michaelson, J. S., Wisniacki, N., Burkly, L. C., & Putterman, C. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.05.003 · Cited by 117
Liu, Z., Huang, X. R., Chen, H., Penninger, J. M., & Lan, H. Y. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.2 · Cited by 115
Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice
Locatelli, I., Sutti, S., Jindal, A., Vacchiano, M., Bozzola, C., Reutelingsperger, C. P. M., Kusters, D. H. M., Bena, S., Parola, M., Paternostro, C., et al. (2014) · Hepatology · doi:10.1002/hep.27141 · Cited by 115
Riedel, J.-H., Becker, M., Kopp, K., Düster, M., Brix, S. R., Meyer‐Schwesinger, C., Kluth, L. A., Gnirck, A.-C., Attar, M., Krohn, S., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016080877 · Cited by 115
Kang, Y. S., Lee, M., Song, H. K., Ko, G. J., Kwon, O. S., Lim, T. K., Kim, S. H., Han, S. Y., Han, K. H., Lee, J. E., et al. (2010) · Kidney International · doi:10.1038/ki.2010.263 · Cited by 113
Anders, H., Belemezova, E., Eis, V., Segerer, S., Vielhauer, V., de Lema, G. P., Kretzler, M., Cohen, C. D., Frink, M., Horuk, R., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000130082.67775.60 · Cited by 111
Effect of TNF-α inhibition on urinary albumin excretion in experimental diabetic rats
Moriwaki, Y., Inokuchi, T., Yamamoto, A., Ka, T., Tsutsumi, Z., Takahashi, S., & Yamamoto, T. (2007) · Acta Diabetologica · doi:10.1007/s00592-007-0007-6 · Cited by 110
IL233, A Novel IL-2 and IL-33 Hybrid Cytokine, Ameliorates Renal Injury
Stremska, M. E., Jose, S. K., Sabapathy, V., Huang, L., Bajwa, A., Kinsey, G. R., Sharma, P. R., Mohammad, S., Rosin, D. L., Okusa, M. D., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016121272 · Cited by 108
PDGF and the progression of renal disease
Boor, P., Ostendorf, T., & Floege, J. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft273 · Cited by 106
Importance of Functional EGF Receptors in Recovery from Acute Nephrotoxic Injury
Wang, Z., Chen, J., Wang, S.-W., Moeckel, G. W., & Harris, R. C. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000098681.56240.1a · Cited by 106
Zeisberg, M., & Kalluri, R. (2008) · Pediatric Nephrology · doi:10.1007/s00467-008-0818-x · Cited by 105
Jin, Y., Liu, R., Xie, J., Xiong, H., He, C., & Chen, N. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.64 · Cited by 105
Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis
Xia, Y., Campbell, S. R., Broder, A. R., Herlitz, L., Abadi, M. A., Wu, P., Michaelson, J. S., Burkly, L. C., & Putterman, C. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.08.008 · Cited by 102
Ucero, A. C., Benito‐Martín, A., Calvo, I. F., Santamaría, B., Blanco, J., López-Novoa, J. M., Ruiz‐Ortega, M., Egido, J., Burkly, L. C., Martínez‐Salgado, C., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.032 · Cited by 101
Antifibrotic actions of mycophenolic acid
Morath, C. P., Schwenger, V., Beimler, J., Mehrabi, A., Schmidt, J., Zeier, M. G., & Muranyi, W. (2006) · Clinical Transplantation · doi:10.1111/j.1399-0012.2006.00597.x · Cited by 100
Modulation of the TGFβ/Smad signaling pathway in mesangial cells by CTGF/CCN2
Wahab, N. A., Weston, B. S., & Mason, R. M. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.03.022 · Cited by 97
Sullivan, T., Miao, Z., Dairaghi, D. J., Krasinski, A., Wang, Y., Zhao, B. N., Baumgart, T., Ertl, L. S., Pennell, A. M. K., Seitz, L., et al. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00316.2013 · Cited by 90
Self-citationHotta, K., Sho, M., Yamato, I., Shimada, K., Harada, H., Akahori, T., Nakamura, S., Konishi, N., Yagita∥, H., Nonomura, K., et al. (2010) · Kidney International · doi:10.1038/ki.2010.379 · Cited by 86
Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis.
Hewitson, T. D., Kelynack, K. J., Tait, M. G., Martic, M., Jones, C. L., Margolin, S. B., & Becker, G. J. (2001) · PubMed · Cited by 86
Amygdalin inhibits renal fibrosis in chronic kidney disease
Guo, J., Wu, W., Sheng, M., Yang, S., & Tan, M. J. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1391 · Cited by 84
Antifibrotic Effect of Tamoxifen in a Model of Progressive Renal Disease
Dellê, H., da Rocha, J. R. C., Cavaglieri, R. C., Vieira, J. M., Malheiros, D. M. A. C., & Noronha, I. L. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011010046 · Cited by 81
Suramin Inhibits Renal Fibrosis in Chronic Kidney Disease
Liu, N., Tolbert, E. M., Pang, M., Ponnusamy, M., Yan, H., & Zhuang, S. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010090956 · Cited by 81
Hallan, S. I., Øvrehus, M. A., Romundstad, S., Rifkin, D. E., Langhammer, A., Stevens, P. E., & Ix, J. H. (2016) · Kidney International · doi:10.1016/j.kint.2016.04.012 · Cited by 80
Role of the TNF pathway in the progression of diabetic nephropathy in KK-Aymice
Omote, K., Gohda, T., Murakoshi, M., Sasaki, Y., Kazuno, S., Fujimura, T., Ishizaka, M., Sonoda, Y., & Tomino, Y. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00509.2013 · Cited by 79
Therrien, F., Agharazii, M., Lebel, M., & Larivière, R. (2012) · American Journal of Nephrology · doi:10.1159/000340033 · Cited by 77
Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice
Santana, A. C., Degaspari, S., Catanozi, S., Dellê, H., Lima, L. D. S., Silva, C., Blanco, P. L., Solez, K., Scavone, C., & Noronha, I. L. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs569 · Cited by 77
Poosti, F., Bansal, R., Yazdani, S., Prakash, J., Post, E., Klok, P. A., van den Born, J., de Borst, M. H., van Goor, H., Poelstra, K., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-258459 · Cited by 76
Trachtman, H., Vento, S., Herreshoff, E. G., Radeva, M., Gassman, J., Stein, D. T., Savin, V. J., Sharma, M., Reiser, J., Wei, C., et al. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0094-5 · Cited by 74
Klein, J., Gonzalez, J., Duchêne, J., Esposito, L., Pradère, J., Neau, E., Delage, C., Calise, D., Ahluwalia, A., Carayon, P., et al. (2008) · The FASEB Journal · doi:10.1096/fj.08-115600 · Cited by 74
Izquierdo, M. C., Sanz, A. B., Mezzano, S. A., Blanco, J., Carrasco, S., Sánchez-Niño, M. D., Benito‐Martín, A., Ruiz‐Ortega, M., Egido, J., & Ortíz, A. (2012) · Kidney International · doi:10.1038/ki.2011.475 · Cited by 72
Interleukin-33 signaling contributes to renal fibrosis following ischemia reperfusion
Liang, H., Xu, F., Wen, X., Liu, H., Wang, H., Zhong, J., Yang, C., & Zhang, B. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.06.031 · Cited by 71
Bernhardt, A., Fehr, A., Brandt, S., Jerchel, S., Ballhause, T. M., Philipsen, L., Stolze, S., Geffers, R., Weng, H., Fischer, K., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.03.035 · Cited by 70
Güngör, Ö., Ünal, H. U., Güçlü, A., Gezer, M., Eyileten, T., Güzel, F. B., Altunören, O., Erken, E., Oğuz, Y., Kocyigit, I. D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178939 · Cited by 70
Sirolimus Therapy of Focal Segmental Glomerulosclerosis Is Associated With Nephrotoxicity
Cho, M. E., Hurley, J. K., & Kopp, J. B. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.10.020 · Cited by 69
Cheng, J., Encarnación, M. M. D., Warner, G. M., et al. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00153.2005 · Cited by 69
Gao, X., Huang, L., Grosjean, F., Esposito, V., Wu, J., Fu, L., Hu, H., Tan, J., He, C., Gray, S., et al. (2011) · Kidney International · doi:10.1038/ki.2010.539 · Cited by 68
He, S., Liu, N., Bayliss, G. P., & Zhuang, S. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00553.2012 · Cited by 66
Connective tissue growth factor is a new ligand of epidermal growth factor receptor
Rayego‐Mateos, S., Rodrigues‐Díez, R., Morgado‐Pascual, J. L., Rodrigues-Díez, R. R., Mas, S., Lavoz, C., Alique, M., Pató, J., Kéri, G., Ortíz, A., et al. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt030 · Cited by 66
Thethi, T. K., Bajwa, M. A., Ghanim, H., Jo, C., Weir, M., Goldfine, A. B., Umpierrez, G. E., Desouza, C. V., Dandona, P., Fang-Hollingsworth, Y., et al. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.01.004 · Cited by 64
Pirfenidone inhibits macrophage infiltration in 5/6 nephrectomized rats
Chen, J., Ni, H.-F., Pan, M., Liu, H., Xu, M., Zhang, M., & Liu, B. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00507.2012 · Cited by 63
TWEAK/Fn14 and Non-Canonical NF-kappaB Signaling in Kidney Disease
Poveda, J., Tábara, L. C., Fernández‐Fernández, B., Martín-Cleary, C., Sanz, A. B., Selgas, R., Ortíz, A., & Sánchez-Niño, M. D. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00447 · Cited by 63
TWEAK-Fn14 Signaling Activates Myofibroblasts to Drive Progression of Fibrotic Kidney Disease
Gomez, I. G., Roach, A. M., Nakagawa, N., Amatucci, A., Johnson, B. G., Dunn, K., Kelly, M. C., Karaca, G., Zheng, T. S., Szak, S. T., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015111227 · Cited by 62
Iekushi, K., Taniyama, Y., Azuma, J., Sanada, F., Kusunoki, H., Yokoi, T., Koibuchi, N., Okayama, K., Rakugi, H., & Morishita, R. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833e4149 · Cited by 61
The management of CKD: A look into the future
Khwaja, A., Kossi, M. E., Floege, J., & Nahas, M. E. (2007) · Kidney International · doi:10.1038/sj.ki.5002489 · Cited by 60
Trentin, P. G., Ferreira, T. P. T., Arantes, A., Ciambarella, B. T., Cordeiro, R. S. B., Flower, R. J., Perretti, M., Martins, M. A., & Silva, P. M. R. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13109 · Cited by 57
Upregulation of Interleukin-33 in obstructive renal injury
Chen, W., Chang, Y., Su, C., Tsai, T., Chen, S., Hsing, C., & Yang, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.04.010 · Cited by 57
Fn14 in podocytes and proteinuric kidney disease
Sánchez-Niño, M. D., Poveda, J., Sanz, A. B., Mezzano, S. A., Carrasco, S., Fernández‐Fernández, B., Burkly, L. C., Nair, V., Kretzler, M., Hodgin, J. B., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.010 · Cited by 54
Lingzhilactones from Ganoderma lingzhi ameliorate adriamycin-induced nephropathy in mice
Yan, Y., Wang, X.-L., Zhou, L., Zhou, F., Li, R., Tian, Y., Zuo, Z., Fang, P., Chung, A. C. K., Hou, F. F., et al. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.11.024 · Cited by 54
Hu, Y., Mou, L., Yang, F., Tu, H., & Lin, W. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5601 · Cited by 54
Kusunoki, H., Taniyama, Y., Azuma, J., Iekushi, K., Sanada, F., Otsu, R., Iwabayashi, M., Okayama, K., Rakugi, H., & Morishita, R. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.176263 · Cited by 53
Botella, L. M., Sanz-Rodríguez, F., Komi, Y., Fernández-L, A., Varela, E., Garrido-Martin, E. M., Narla, G., Friedman, S. L., & Kojima, S. (2008) · Biochemical Journal · doi:10.1042/bj20081434 · Cited by 52
Han, H., Zhu, J., Wang, Y., Zhu, Z., Chen, Y., Lu, L., Jin, W., Yan, X., & Zhang, R. (2016) · The Journal of Pathology · doi:10.1002/path.4831 · Cited by 52
Self-citationActivation of annexin A1 signalling in renal fibroblasts exerts antifibrotic effects
Neymeyer, H., Labes, R., Reverte, V., Sáez, F., Stroh, T., Dathe, C., Hohberger, S. F., Zeisberg, M., Muller, G. A., Salazar, F. J., et al. (2015) · Acta Physiologica · doi:10.1111/apha.12586 · Cited by 50
Blockade of the Kinin B1 Receptor Ameloriates Glomerulonephritis
Klein, J., Gonzalez, J., Decramer, S., Bandin, F., Neau, E., Salant, D. J., Heeringa, P., Pesquero, J. B., Schanstra, J. P., & Bascands, J. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009090887 · Cited by 50
αKlotho and Chronic Kidney Disease
Neyra, J. A., & Hu, M. C. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.02.007 · Cited by 45
Liu, Q., Ye, J., Deng, Z., Yu, L., Sun, Q., & Li, S. (2015) · Iranian Journal of Kidney Diseases · Cited by 44
Interaction between TGF-β and ACE2-Ang-(1–7)-Mas pathway in high glucose-cultured NRK-52E cells
Chou, C., Chuang, L., Lu, C., & Guh, J. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.11.004 · Cited by 43
Present and Future in the Treatment of Diabetic Kidney Disease
Quiroga, B., Arroyo, D., & de Arriba, G. (2015) · Journal of Diabetes Research · doi:10.1155/2015/801348 · Cited by 42
Nitta, K., Shi, S., Nagai, T., Kanasaki, M., Kitada, M., Srivastava, S. P., Haneda, M., Kanasaki, K., & Koya, D. (2016) · BioMed Research International · doi:10.1155/2016/9172157 · Cited by 42
Carlos, C. P., Sonehara, N. M., Oliani, S. M., & Burdmann, E. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103660 · Cited by 40
Deletion of bradykinin B1 receptor reduces renal fibrosis
Wang, P. H. M., Cenedeze, M. A., Campanholle, G., Malheiros, D. M. A. C., Torres, H. A. M., Pesquero, J. B., Pacheco‐Silva, Á., & Câmara, N. O. S. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.10.018 · Cited by 40
Mesenchymal Stem Cell-based Therapy as a New Horizon for Kidney Injuries
Roushandeh, A. M., Bahadori, M., & Roudkenar, M. H. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.03.007 · Cited by 40
Volpini, R. A., Costa, R. S., da Silva, C. G. A., & Coimbra, T. M. (2004) · Nephron Physiology · doi:10.1159/000081558 · Cited by 37
Chronic inhibition of nuclear factor kappa B attenuates aldosterone/salt-induced renal injury
Ding, W. Q., Yang, L., Zhang, M., & Gu, Y. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.02.022 · Cited by 36
MnTBAP Therapy Attenuates Renal Fibrosis in Mice with 5/6 Nephrectomy
Yu, J. J., Mao, S., Zhang, Y., Gong, W., Jia, Z., Huang, S., & Zhang, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7496930 · Cited by 34
Novel Epidermal Growth Factor Receptor Inhibitor Attenuates Angiotensin II–Induced Kidney Fibrosis
Qian, Y., Peng, K., Qiu, C., Skibba, M. E., Huang, Y., Xu, Z., Zhang, Y., Hu, J., Liang, D., Zou, C., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.228080 · Cited by 33
Self-citationFluorofenidone Attenuates Diabetic Nephropathy and Kidney Fibrosis in db/db Mice
Wang, L. H., Liu, J. S., Ning, W. B., Yuan, Q. J., Zhang, F. F., Peng, Z., Lu, M. M., Luo, R., Fu, X., Hu, G. Y., et al. (2011) · Pharmacology · doi:10.1159/000329419 · Cited by 32
Suramin Alleviates Glomerular Injury and Inflammation in the Remnant Kidney
Liu, N., He, S., Tolbert, E. M., Gong, R., Bayliss, G. P., & Zhuang, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036194 · Cited by 31
Oh, Y. J., An, J. N., Kim, C. T., Yang, S. H., Lee, H., Kim, D. K., Joo, K. W., Paik, J. H., Kang, S., Park, J. T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132826 · Cited by 29
Shin, H., & Kang, H. (2016) · Journal of Nephrology · doi:10.1007/s40620-016-0280-y · Cited by 27
Antifibrotic vitamin D analogs
Bonventre, J. V. (2013) · Journal of Clinical Investigation · doi:10.1172/jci72748 · Cited by 25
New EGFR inhibitor, 453, prevents renal fibrosis in angiotensin II-stimulated mice
Skibba, M. E., Qian, Y., Bao, Y., Lan, J., Peng, K., Zhao, Y., Zhong, P., Hu, J., Li, X., & Liang, G. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.08.009 · Cited by 25
Dhruv, H., Loftus, J. C., Narang, P., Petit, J. L., Fameree, M., Burton, J., Tchegho, G., Chow, D. C., Yin, H., Al‐Abed, Y., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.493536 · Cited by 23
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and kidney disease
Ruiz‐Ortega, M., Ortíz, A., & Ramos, A. M. (2013) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000437331.23794.81 · Cited by 23
Takeji, M., Kawada, N., Moriyama, T., Nagatoya, K., Oseto, S., Akira, S., Hori, M., Imai, E., & Miwa, T. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000136426.01160.2f · Cited by 22
Tapia, E., García‐Arroyo, F. E., Silverio, O., Rodriguez-Alcocer, A. N., Jiménez-Flores, A. B., Cristóbal, M., Arellano, A., Soto, V., Osorio‐Alonso, H., Molina‐Jijón, E., et al. (2016) · Free Radical Research · doi:10.1080/10715762.2016.1174776 · Cited by 22
Duitman, J., Borensztajn, K., Pulskens, W. P., Leemans, J. C., Florquin, S., & Spek, C. A. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.127 · Cited by 19
Chuang, S.-T., Kuo, Y., & Su, M. (2014) · Scientific Reports · doi:10.1038/srep05814 · Cited by 19
Demirtaş, L., Türkmen, K., Kandemır, F. M., Özkaraca, M., Küçükler, S., Gürbüzel, M., & Çomaklı, S. (2016) · Renal Failure · doi:10.3109/0886022x.2016.1165034 · Cited by 19
Park, G. H., Shinn, H. K., Kang, J.-H., Na, W., Kim, Y. H., & Park, C. (2016) · International Neurourology Journal · doi:10.5213/inj.1632578.289 · Cited by 17
Yokote, S., Katsuoka, Y., Yamada, A., Ohkido, I., & Yokoo, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-14492-9 · Cited by 17
Vahed, S. Z., Nikasa, P., & Ardalan, M. (2013) · Nephro-Urology Monthly · doi:10.5812/numonthly.16179 · Cited by 15
Mansell, H., Soliman, M. A., Elmoselhi, H., & SHOKER, A. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142141 · Cited by 15
Haller, S. T., Kumarasamy, S., Folt, D. A., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.08.015 · Cited by 14
Potential New Treatments for Diabetic Kidney Disease
Kania, D. S., Smith, C. T., Nash, C. L., Gonzalvo, J. D., Bittner, A., & Shepler, B. M. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.10.004 · Cited by 12
Rampanelli, E., Rouschop, K. M. A., Teske, G. J. D., Claessen, N., Leemans, J. C., & Florquin, S. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00340.2013 · Cited by 11
Mihovilović, K., Maksimović, B., Kocman, B., Guštin, D., Vidas, Ž., Bulimbašić, S., Ljubanović, D. G., Matovinović, M. S., & Knotek, M. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005005 · Cited by 11
Liao, X., Zhang, L., Chen, G.-T., Yan, R., Sun, H., Guo, H. M., & Liu, Q. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.07.001 · Cited by 10
Augmenter of liver regeneration ameliorates renal fibrosis in rats with obstructive nephropathy
Chen, G.-T., Zhang, L., Liao, X.-H., Yan, R., Li, Y., Sun, H., Guo, H. M., & Liu, Q. (2014) · Bioscience Reports · doi:10.1042/bsr20140038 · Cited by 9
Cited by
Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications
Weiskirchen, R., Weiskirchen, S., & Tacke, F. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.06.003 · Cited by 538
Emerging Targets in Type 2 Diabetes and Diabetic Complications
Demir, S., Nawroth, P. P., Herzig, S., & Ekim Üstünel, B. (2021) · Advanced Science · doi:10.1002/advs.202100275 · Cited by 525
Signaling pathways of chronic kidney diseases, implications for therapeutics
Yuan, Q., Tang, B., & Zhang, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01036-5 · Cited by 453
Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2
Stenvinkel, P., Chertow, G. M., Devarajan, P., Levin, A., Andreoli, S. P., Bangalore, S., & Warady, B. A. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.04.023 · Cited by 297
Peng, X., Wang, Y., Li, H., Fan, J., Shen, J., Yu, X., Zhou, Y., & Mao, H. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1483-7 · Cited by 183
Self-citation
Metadata
- Authors
- Lv, W., Booz, G. W., Wang, Y., Fan, F., & Roman, R. J.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 820
- Pages
- 65-76
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2772570025
- Cited by
- 338
- References
- 150
- FWCI
- 14.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.